| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000468543 |
| P698 | PubMed publication ID | 28494468 |
| P50 | author | Alessandro Serretti | Q56380923 |
| P2093 | author name string | Laura Mandelli | |
| Ashwin A Patkar | |||
| Changsu Han | |||
| Chi-Un Pae | |||
| Prakash S Masand | |||
| Soo-Jung Lee | |||
| Concetta Crisafulli | |||
| Tae-Youn Jun | |||
| Marco Calabrò | |||
| Antonella Sidoti | |||
| P2860 | cites work | Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 |
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks | Q24570122 | ||
| MAP'ing CNS development and cognition: an ERKsome process | Q24621710 | ||
| No evidence for association between 19 cholinergic genes and bipolar disorder | Q24645820 | ||
| Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder | Q24655630 | ||
| Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
| The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice | Q28266622 | ||
| Whole-genome association study of bipolar disorder | Q28271419 | ||
| Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 | Q29417143 | ||
| Controlling the false discovery rate in behavior genetics research | Q29614833 | ||
| Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data. | Q30797410 | ||
| Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia | Q33872654 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| Genetic architectures of psychiatric disorders: the emerging picture and its implications | Q33949729 | ||
| PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway | Q56972839 | ||
| Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned | Q34147518 | ||
| Genetic Association Study of the Alpha 7 Nicotinic Receptor (CHRNA7) with the Development of Schizophrenia and Bipolar Disorder in Korean Population | Q34165058 | ||
| Linking Molecules to Mood: New Insight Into the Biology of Depression | Q34540304 | ||
| CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls | Q34599807 | ||
| Neuroprotective effects of lithium in cultured cells and animal models of diseases. | Q34692758 | ||
| Nicotinic acetylcholine receptors as targets for antidepressants. | Q34761238 | ||
| MAPK, CREB and zif268 are all required for the consolidation of recognition memory | Q35124837 | ||
| Genetic Variation in CACNA1C Affects Brain Circuitries Related to Mental Illness | Q35764284 | ||
| Association of depressive disorders, depression characteristics and antidepressant medication with inflammation | Q35844355 | ||
| Efficacy of atypical antipsychotics in bipolar disorder | Q35999567 | ||
| The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample | Q36010076 | ||
| The human clinical phenotypes of altered CHRNA7 copy number | Q36144791 | ||
| Genome-wide discovered psychosis-risk gene ZNF804A impacts on white matter microstructure in health, schizophrenia and bipolar disorder | Q36663333 | ||
| Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci. | Q36932866 | ||
| Circadian oscillation of hippocampal MAPK activity and cAmp: implications for memory persistence. | Q37409553 | ||
| Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients | Q37663637 | ||
| Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors | Q37799094 | ||
| The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes | Q37896949 | ||
| Inflammation and depression | Q38007134 | ||
| Cost of illness for bipolar disorder: a systematic review of the economic burden | Q38174209 | ||
| Cellular models to study bipolar disorder: A systematic review | Q38526370 | ||
| Neurodevelopmental origins of bipolar disorder: iPSC models | Q38647935 | ||
| Genetics of Bipolar Disorder: Recent Update and Future Directions. | Q38733245 | ||
| Effects of intracellular calcium on cell survival and the MAPK pathway in a human hormone-dependent leukemia cell line (TF-1). | Q40576335 | ||
| Calcium induces cell survival and proliferation through the activation of the MAPK pathway in a human hormone-dependent leukemia cell line, TF-1. | Q40663206 | ||
| PBAT: a comprehensive software package for genome-wide association analysis of complex family-based studies. | Q42064007 | ||
| Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia. | Q42171591 | ||
| Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway. | Q43190883 | ||
| Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients | Q46051996 | ||
| Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. | Q46684572 | ||
| FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: basal contents and effects of psychotropic treatments | Q48244234 | ||
| The CACNA1C risk variant for bipolar disorder influences limbic activity | Q48254927 | ||
| ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype | Q48826306 | ||
| Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation | Q48892558 | ||
| CHRNA7 haplotypes are associated with impaired attention in euthymic bipolar disorder. | Q50803294 | ||
| The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. | Q55054198 | ||
| Bipolar Disorder | Q56091575 | ||
| P433 | issue | 3 | |
| P921 | main subject | bipolar disorder | Q131755 |
| neuroplasticity | Q849491 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 159-168 | |
| P577 | publication date | 2017-05-12 | |
| P1433 | published in | Neuropsychobiology | Q7002585 |
| P1476 | title | Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1. | |
| P478 | volume | 74 |
| Q92227616 | Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1 |
| Q90149649 | Horizontal and vertical integrative analysis methods for mental disorders omics data |
| Q58766074 | Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample |
Search more.